Given the rise in newborn screening for ALD since 2019, and the untapped potential of existing genetic research, the Halls ...
Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...
Viking Therapeutics Inc (VKTX) reports significant R&D progress and financial bolstering despite increased losses and operational challenges.
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...
Julius Randle, who has been the Timberwolves' second leading scorer since coming to the team in an preseason trade, will be ...
Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results